rs79891110

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PS3PM1PM2PP3_ModeratePP5_Very_Strong

The NM_000719.7(CACNA1C):​c.1216G>A​(p.Gly406Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 16/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000223326: Published functional studies demonstrate G406R reduces channel inactivation, leading to aberrant intracellular calcium levels in multiple tissues (PMID:15454078)" and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CACNA1C
NM_000719.7 missense, splice_region

Scores

15
3
Splicing: ADA: 0.9697
1
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:11O:2

Conservation

PhyloP100: 10.0

Publications

224 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000223326: Published functional studies demonstrate G406R reduces channel inactivation, leading to aberrant intracellular calcium levels in multiple tissues (PMID: 15454078); SCV000253858: Experimental studies have shown that this missense change affects CACNA1C function (PMID: 15454078, 15863612, 18250309, 19074970, 26822303).; SCV002657014: Functional studies demonstrated altered gating kinetics and prolonged action potential duration, while mouse models with this mutation showed neurobehavioral and brain changes consistent with TS clinical findings (Splawski I et al. Cell, 2004 Oct;119:19-31; Bader PL et al. Proc. Natl. Acad. Sci. U.S.A., 2011 Sep;108:15432-7; Krey JF et al. Nat. Neurosci., 2013 Feb;16:201-9).; SCV003919754: "In vitro functional studies demonstrate a deleterious effect of this variant on calcium channel function." PMID:15454078; SCV000996245: A functional study showed this variant impairs voltage-dependent channel inactivation causing maintained inward calcium currents (PMID: 15454078).
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000719.7
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.936
PP5
Variant 12-2504944-G-A is Pathogenic according to our data. Variant chr12-2504944-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 17632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.1216G>Ap.Gly406Arg
missense splice_region
Exon 8 of 47NP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.1217+405G>A
intron
N/ANP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.1216G>Ap.Gly406Arg
missense splice_region
Exon 8 of 50NP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.1216G>Ap.Gly406Arg
missense splice_region
Exon 8 of 47ENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.1306G>Ap.Gly436Arg
missense splice_region
Exon 8 of 50ENSP00000507184.1A0A804HIR0
CACNA1C
ENST00000347598.9
TSL:1
c.1216G>Ap.Gly406Arg
missense splice_region
Exon 8 of 49ENSP00000266376.6Q13936-11

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152054
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1312642
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
661428
African (AFR)
AF:
0.00
AC:
0
AN:
30456
American (AMR)
AF:
0.00
AC:
0
AN:
44402
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25156
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39042
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82952
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5516
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
976280
Other (OTH)
AF:
0.00
AC:
0
AN:
55552
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152172
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74392
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
41532
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67996
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
not provided (4)
2
-
-
Timothy syndrome (3)
1
-
-
CACNA1C-related disorder (1)
1
-
-
Cardiovascular phenotype (1)
1
-
-
Long QT syndrome (1)
1
-
-
Long QT syndrome 8 (1)
1
-
-
Timothy syndrome;C2678478:Brugada syndrome 3;C5774213:Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures;CN260585:Long QT syndrome 8 (1)
-
-
-
Congenital long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
CardioboostArm
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
35
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.68
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.95
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Pathogenic
0.80
D
MetaRNN
Pathogenic
0.94
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.3
M
PhyloP100
10
PrimateAI
Pathogenic
0.96
D
PROVEAN
Pathogenic
-6.8
D
REVEL
Pathogenic
0.96
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.023
D
Polyphen
1.0
D
Vest4
0.95
MutPred
0.71
Loss of ubiquitination at K410 (P = 0.0816)
MVP
0.99
MPC
2.4
ClinPred
1.0
D
GERP RS
5.3
gMVP
0.99
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.97
dbscSNV1_RF
Benign
0.67
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79891110; hg19: chr12-2614110; COSMIC: COSV100223378; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.